December 26, 2008 — Trocar-guided transvaginal mesh surgery for pelvic organ prolapse results in good clinical outcomes at 1 year, according to the results of a prospective, multicenter cohort study ...

Please provide your email address to receive an email when new articles are posted on . Transvaginal mesh was noninferior to native tissue repair in women with pelvic organ prolapse at 36 months, ...

October 21, 2008 — Clinicians should receive specialized training for the transvaginal placement of mesh products and be vigilant for adverse events, the US Food and Drug Administration (FDA) warned ...

Manufacturers of surgical mesh products must stop selling and distributing their products in the United States immediately, the US Food and Drug Administration ordered Tuesday. The FDA said it "has ...

Transvaginally placed surgical mesh may pose greater safety risks for women with pelvic organ prolapse (POP) undergoing reconstructive surgery than other surgical options — without evidence of greater ...

The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) ...

NEW YORK (Reuters) - Boston Scientific Corp’s back-to-back losses in the first two federal trials over its transvaginal mesh devices could drive up the cost of resolving thousands of similar lawsuits, ...

Women with vaginal discomfort Is the risk of depression or self-harm greater in women who have experienced complications following transvaginal mesh midurethral sling placement? Women with ...

Johnson & Johnson, a global healthcare giant based in New Brunswick, New Jersey, lost a product liability lawsuit surrounding its transvaginal mesh implants manufactured by Ethicon, a subsidiary of ...